GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neurotech International Ltd (ASX:NTI) » Definitions » EPS without NRI

Neurotech International (ASX:NTI) EPS without NRI : A$-0.01 (TTM As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Neurotech International EPS without NRI?

Neurotech International's earnings per share without non-recurring items for the six months ended in Dec. 2023 was A$-0.00. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.01.

During the past 3 years, the average earnings per share (NRI) Growth Rate was 3.10% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 25.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Neurotech International's EPS without NRI or its related term are showing as below:

ASX:NTI' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 3.1   Med: 30.75   Max: 40.7
Current: 3.1

During the past 7 years, Neurotech International's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 40.70% per year. The lowest was 3.10% per year. And the median was 30.75% per year.

ASX:NTI's 3-Year EPS without NRI Growth Rate is ranked worse than
57.24% of 704 companies
in the Medical Devices & Instruments industry
Industry Median: 9.15 vs ASX:NTI: 3.10

Neurotech International's EPS (Diluted) for the six months ended in Dec. 2023 was A$-0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.01.

Neurotech International's EPS (Basic) for the six months ended in Dec. 2023 was A$-0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.01.


Neurotech International EPS without NRI Historical Data

The historical data trend for Neurotech International's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurotech International EPS without NRI Chart

Neurotech International Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EPS without NRI
Get a 7-Day Free Trial -0.02 -0.01 -0.02 -0.01 -0.01

Neurotech International Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -0.01 -0.01 -

Competitive Comparison of Neurotech International's EPS without NRI

For the Medical Devices subindustry, Neurotech International's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurotech International's PE Ratio without NRI Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Neurotech International's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Neurotech International's PE Ratio without NRI falls into.



Neurotech International EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neurotech International  (ASX:NTI) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Neurotech International EPS without NRI Related Terms

Thank you for viewing the detailed overview of Neurotech International's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurotech International (ASX:NTI) Business Description

Traded in Other Exchanges
N/A
Address
145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009
Neurotech International Ltd is a medical device and solutions company. It researches, designs, markets, and produces wearable neurotechnology devices to assist with neurological conditions such as autism. Geographically, all the business activities of the firm function through the region of Australia. It operates in one segment named Medical Device Development and Distribution.

Neurotech International (ASX:NTI) Headlines

From GuruFocus

9 Stocks With Yields Over 10% And Buy Or Better Rating

By Dividend Dividend 08-17-2013

13 Stocks With Dividend Yields Over 10%

By Dividend Dividend 11-12-2014

20 Stocks with Yields over 10% and Highest Buy Ratings

By Dividend Dividend 01-17-2013

How to Capitalize on the Bakken Oil Boom

By Vitaliy Katsenelson Vitaliy Katsenelson 11-09-2013